PRESS RELEASE published on 02/18/2026 at 07:30, 6 months 21 days ago Informations privilégiées / Autres communiqués GenSight Biologics renforce son équipe réglementaire aux États-Unis et en Europe avec deux nominations clés. Fang Li nommée directrice exécutive des Affaires réglementaires et de la Qualité, Sabrina Chekroun devient Vice-Présidente Senior des Affaires réglementaires et de la Qualité Nominations Affaires Réglementaires GenSight Biologics Fang Li Sabrina Chekroun
PRESS RELEASE published on 02/18/2026 at 07:20, 6 months 21 days ago Dexus Exchangeable Notes - Notice to Noteholders Dexus Finance Pty Ltd adjusts Exchange Price for A$500 million 3.50% Coupon Guaranteed Exchangeable Notes Due 2027. Contact for more info Financial Announcement Noteholders Dexus Finance Exchange Price Guaranteed Notes
PRESS RELEASE published on 02/18/2026 at 07:15, 6 months 21 days ago Intershop publishes preliminary figures for the financial year 2025 Intershop Communications AG publishes provisional figures for the financial year 2025, with stable cloud revenues and significant operational milestones achieved EBIT Intershop Communications AG Cloud Revenues Operational Milestones Financial Year 2025
PRESS RELEASE published on 02/18/2026 at 07:00, 6 months 21 days ago SAF-HOLLAND SE: Preliminary results for fiscal year 2025 show solid profitability in a challenging market environment SAF-HOLLAND SE's preliminary results for FY 2025 show solid profitability amidst market challenges. Group sales decline to EUR 1,734 million, with adjusted EBIT margin at 9.5% Profitability Market Environment Preliminary Results SAF-HOLLAND SE FY 2025
PRESS RELEASE published on 02/18/2026 at 07:00, 6 months 21 days ago Straumann Group delivers strong 2025 performance with continued market share gains, innovation and strategic progress Straumann Group reports strong 2025 performance with 8.9% organic revenue growth, 26.5% core EBIT margin, and CHF 477.8 million core net profit. Key innovations and strategic partnerships drove growth Innovation Revenue Growth EBIT Margin Straumann Group 2025 Performance
PRESS RELEASE published on 02/18/2026 at 07:00, 6 months 21 days ago Sandoz receives US FDA approval to expand Enzeevu® (aflibercept-abzv) label for multiple retinal indications Sandoz receives US FDA approval to expand Enzeevu® (aflibercept-abzv) label to include multiple retinal indications, offering new treatment options for retinal diseases FDA Approval Vision Care Sandoz Enzeevu Retinal Indications
REGULATED PRESS RELEASE published on 02/18/2026 at 07:00, 6 months 21 days ago bioMérieux launches SMARTBIOME™ to help food manufacturers gain deeper insights into spoilage and protect product quality bioMérieux launches SMARTBIOME™, an innovative solution combining DNA sequencing, bioinformatics, and microbiology expertise to help food manufacturers understand, control, and prevent spoilage, improving product quality and consumer safety BioMérieux DNA Sequencing SMARTBIOME™ Food Manufacturers Microbiological Spoilage
REGULATED PRESS RELEASE published on 02/18/2026 at 07:00, 6 months 21 days ago bioMérieux lance SMARTBIOME™ pour aider les industriels de l’agroalimentaire à mieux comprendre les altérations et protéger la qualité des produits bioMérieux lance SMARTBIOME™ pour aider les industriels de l’agroalimentaire à mieux comprendre les altérations et protéger la qualité des produits. Une solution innovante combinant séquençage ADN, bio-informatique et expertise microbiologique Agroalimentaire BioMérieux Séquençage ADN SMARTBIOME Altérations Microbiologiques
PRESS RELEASE published on 02/18/2026 at 07:00, 6 months 21 days ago ACTIA GROUP : CHIFFRE D'AFFAIRES DU 4EME TRIMESTRE ET DE L'ANNEE 2025 ACTIA Group clôture un exercice 2025 maîtrisé avec une discipline financière renforcée, soutenu par la diversification sectorielle et géographique. Perspectives 2026 axées sur la croissance modérée et l'innovation Chiffre D'affaires Innovation Exercice 2025 ACTIA Group Croissance Modérée
PRESS RELEASE published on 02/18/2026 at 01:00, 6 months 21 days ago urban-gro, Inc. Completes Merger with Flash Sports and Media Inc., Providing Shareholders with Access to the Rapidly Evolving Sports & Media Digital Landscape urban-gro, Inc. completes merger with Flash Sports and Media, Inc., acquiring 100% shares. The strategic move enables entry into high-growth sports, media & experiential platform with diversified revenue-generating assets Merger Urban-gro Experiential Marketing Sports Media Flash Sports And Media
Published on 09/11/2026 at 17:00, 2 hours 30 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/11/2026 at 17:00, 2 hours 30 minutes ago Critical Elements sélectionné pour inclusion dans le prospectus du sommet Canadien de l'investissement, mettant le projet en valeur auprès d'investisseurs mondiaux de premier plan
Published on 09/11/2026 at 15:25, 4 hours 5 minutes ago Revolve Signs Agreement to Acquire 9.6 MW Operating Wind Project in the US and Secures Project-Level Debt Financing with EDC and Vancity
Published on 09/11/2026 at 15:00, 4 hours 30 minutes ago Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update
Published on 09/11/2026 at 14:30, 5 hours ago AIAI Holdings Enters into Extended Lock-up Agreements to Protect Long-Term Stockholder Value
Published on 09/11/2026 at 18:15, 1 hour 15 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 18:00, 1 hour 30 minutes ago ROCTOOL: INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 09/11/2026 at 18:00, 1 hour 30 minutes ago ROCTOOL: INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 09/11/2026 at 07:00, 12 hours 30 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 12 hours 30 minutes ago Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 12 hours 30 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 12 hours 30 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ